ModifyHealth, a leader in food-as-medicine solutions, raised $13.5 million in a Series C funding round led by the Dohmen Company Foundation (DCF) via its Dohmen Impact Investment Fund. Existing investors RC Capital and Nashville Capital Network also participated. The funding will support growth initiatives, technology enhancements and expanded operations aimed at increasing accessibility to ModifyHealth’s services. The company provides medically tailored meals and telenutrition to address chronic conditions like diabetes, hypertension and obesity. ModifyHealth’s customizable meal plans, including Low-FODMAP and Mediterranean options, are paired with live nutrition coaching and digital education, offering patients practical tools for sustainable health improvements.

Rosy Soil, a sustainable soil company founded in 2022, raised $3.6 million in a seed funding round led by Draper Associates, Superorganism, Climate Capital and Boost VC. Other notable backers include Seth Goldman (Honest Tea), Brandin Cohen (LiquidIV) and Ben Chesler (Imperfect Foods). The funding will drive product development, team growth and expanded retail partnerships with companies like Target and independent nurseries across the U.S. Rosy Soil develops biochar-based potting mixes, an eco-friendly alternative to traditional peat-based soils. Biochar, a carbon-negative material created through pyrolysis, enhances soil health and plant growth while sequestering CO2. This innovation mitigates the environmental damage caused by peat extraction, which contributes to climate change and habitat loss.

Marine Biologics has acquired Spoitz Enterprises, a Canadian leader in macroalgae biochemical engineering, to expand its capabilities in developing macroalgae applications for food, cosmetics and materials. Financial terms were not disclosed. The acquisition strengthens Marine Biologics’ molecular data platform, enabling innovative product solutions and addressing supply chain bottlenecks. Spoitz’s advanced post-harvest technology and compositional data expertise will complement Marine Biologics’ resources, with a focus on improving taste and functionality in food and beverage applications. Spoitz will operate as a subsidiary, continuing its testing services and quality management solutions. Additionally, the newly established Berkeley Innovation Lab will accelerate molecular design informed by macroalgae’s unique properties.

Swiss food tech startup Yeastup secured $9.9 million in Series A funding, led by Beyond Impact, Gentian Investments, Newtree Impact and Angel House. Additional support includes $2.75 million in grants from Innosuisse and regional development funds. The capital will transform a former Cremo dairy factory into a facility producing proteins and functional ingredients from spent brewer’s yeast, upcycling 2,000 tonnes annually. Yeastup’s patented process extracts high-value ingredients like Yeastin proteins, beta-glucan and mannoprotein, reducing fermentation bitterness while recovering water for sustainability. Yeastin serves as an egg replacement in vegan mayo, baked goods and meat alternatives, boasting a protein digestibility score of 1 and 74% fewer emissions than pea protein. The facility, opening in 2025, supports rising demand for alternative proteins in food, nutraceuticals and cosmetics.